Notes to editor
This press release accompanies a presentation at ESC Congress 2025.
It does not necessarily reflect the opinion of the European Society of Cardiology.
ESC Press Office
Tel: +33 6 61 40 18 84
Email: press@escardio.org
Follow European Society of Cardiology News on LinkedIn
Funding: This work was supported by a grant from the Ministry of Health and Welfare and the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare and the Ministry of Food and Drug Safety).
Disclosures: Professor Kim has no relevant financial or non-financial interests to disclose. Doctor Hui-Nam Pak is the inventor of a patent application (Patent Number: 10-2257498) for the CUVIA system, a patented technology that was utilised to create the digital twin.
References and notes:
1‘CUVIA: digital twin-guided rotor ablation for persistent atrial fibrillation’ presented during HOT LINE 8 on 31 August 2025 at 18:00 to 18:10 in Madrid (Main Auditorium).
2Global surge in serious heart rhythm disorders sparks urgent call to action from experts: 1 in 3 people at risk (www.escardio.org).
3Deisenhofer I, Albenque JP, Busch S, et al. Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial. Nat Med. 2025;31:1286–1293.
About ESC Congress 2025
It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in Madrid and online – from 29 August to 1 September 2025. Explore the scientific programme. More information is available from the ESC Press Office at press@escardio.org.
About the European Society of Cardiology
The ESC brings together healthcare professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.